P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL-1)

Autor: M.C. Minnema, A. Chari, C. Touzeau, C. Schinke, J. Berdeja, A. Oriol, de Donk N. van, P.R. Otero, E. Askari, M.V. Mateos, L.J. Costa, J. Caers, L. Rasche, A. Krishnan, D. Vishwamitra, X. Ma, X. Qin, K.S. Gries, M. Campagna, T. Masterson, B. Hilder, J. Tolbert, T. Renaud, J.D. Goldberg, C. Heuck, J.S. Miguel, P. Moreau

Publikováno v: HemaSphere, Vol 7, Iss S2, Pp 26-27 (2023)

Externí odkaz: https://doaj.org/article/b8eaf76221a94514a0fcd872be55e861

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Multiple myeloma

Autor: Jesús F. San-Miguel, U. Mey, Mario Boccadoro, Thierry Facon, Roman Hájek, P. Moreau, M.V. Mateos, E. Terpos, M.A. Dimopoulos, Michele Cavo, Fredrik Schjesvold, H. Goldschmidt, Gordon Cook, Michel Delforge, Sonja Zweegman, H. Einsele, Pieter Sonneveld

Publikováno v: EHA Guidelines Committee & ESMO Guidelines Committee 2021, ' Multiple myeloma : EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up † ', Annals of Oncology, vol. 32, no. 3, pp. 309-322 . https://doi.org/10.1016/j.annonc.2020.11.014
Annals of Oncology, 32(3), 309-322. Oxford University Press
Annals of Oncology, 32(3), 309-322. Elsevier Ltd.
Dimopoulos, M A, Moreau, P, Terpos, E, Mateos, M V, Zweegman, S, Cook, G, Delforge, M, Hájek, R, Schjesvold, F, Cavo, M, Goldschmidt, H, Facon, T, Einsele, H, Boccadoro, M, San-Miguel, J, Sonneveld, P & Mey, U 2021, ' Multiple Myeloma : EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up ', HemaSphere . https://doi.org/10.1097/HS9.0000000000000528
HemaSphere

ispartof: HEMASPHERE vol:5 issue:2 ispartof: location:United States status: published

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60c3c6609190b33f4f46700bb41d85c
https://pure.eur.nl/en/publications/9ef136fc-4fcf-4dc0-ba1f-c56b9dd51cd7

PERFIL DE CÉLULAS B NA MEDULA ÓSSEA E SANGUE PERIFÉRICO DE PACIENTES COM MIELOMA MÚLTIPLO APÓS TRANSPLANTE AUTÓLOGO DE CÉLULAS TRONCO HEMATOPOIÉTICAS

Autor: A. Orfao, AB Salgado, Eduarda Barbosa, Luzalba Sanoja-Flores, A Maiolino, Elaine Sobral da Costa, M.V. Mateos, N. Puig, Jjmv Dongen, Rjp Magalhães, Roberia Pontes, Juan Flores-Montero

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S209-S210 (2021)

Objetivos: A recuperação das células B é uma das características dos pacientes com MM que alcançam o controle da doença em longo prazo. Recentemente, a cinética de reconstituição de células B na medula óssea (MO) de pacientes com MM duran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ff2203256c147e07b4518aa390c03d
http://www.sciencedirect.com/science/article/pii/S2531137921005022

TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D (GPRC5D) CD3 BISPECIFIC ANTIBODY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 STUDY RESULTS

Autor: Jesus G. Berdeja, BW Hilderq, Thomas J. Prior, Monique C. Minnema, Luciano J. Costa, Paula Rodriguez-Otero, Aparna Krishnan, Jenna D. Goldberg, Ajai Chari, Albert Oriol, Jeffery S. Russell, Raluca Verona, E Askari, S Girgisq, M.V. Mateos, Nwv Donk

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S215-S216 (2021)

Objectives Patients with MM continue to relapse on current therapies, stressing the need for new immunotherapy targets. GPRC5D is an orphan receptor that is expressed on malignant plasma cells in MM. Talquetamab (JNJ-64407564) is a bispecific IgG4 an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8da3109e032ff363a6718632aa42fb0
http://www.sciencedirect.com/science/article/pii/S2531137921005125